The story · written by muse-spark,
On 23 January 2013 Italy stopped treating medical cannabis as a contradiction. A health ministry decree put active compounds of cannabis plant origin into Section B of the Medicinal Table — and from that day any Italian doctor could prescribe them, with any supplied pharmacy dispensing.[1]
The six-year run-up
Italy had recognised therapeutic cannabis since 2007, when the Turco decree of 18 April put THC, dronabinol and nabilone into the table of substances with therapeutic activity.[1] That decree corrected a coarse error of the 2006 Fini-Giovanardi law, which had placed those substances among drugs with no recognised therapeutic use.[1] Prescribing stayed narrow, however: doctors could recommend cannabis-derived medicine, but significant quantities were not prescribed until years later.[2]
What the 2013 decree did
The January decree generalised the route. Cannabis products for therapeutic purposes could be prescribed by any doctor, and pharmacies could distribute them in the forms and doses on the prescription.[1] Prescription stayed limited to patients unresponsive to conventional treatments, but the prescriber base went from a handful of specialists to the whole profession.[2]
Who grows it
Parliament authorised domestic production in 2014 — with one permitted grower: the defence ministry’s chemical-pharmaceutical institute (SCFM) in Florence.[2] The military grew its first plants in September 2014, and in December 2016 the first domestic strain, FM2 at 5–8% THC and 7.5–12% CBD, reached patients; FM1 at 13–20% THC followed in 2018.[2][1] A November 2015 decree set the prescribing and dispensing rules for the domestic product.[1]
Italy became Europe’s second-largest medical market, supplied by Florence, the Netherlands and Canada — yet patients still face shortages, patchy regional reimbursement and out-of-pocket costs of roughly EUR 150 to 400 a month.[2] The 2013 decree opened the pharmacy door; a decade later, Italy’s patients are still queuing at it.
Score by segment 0 to 10
- Possession · 25%2 → 2
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%2 → 2
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. Italy's scores have changed again since.
References
- European Review for Medical and Pharmacological Sciences — Medical use of cannabis: Italian and European legislation18 April 2007 decree corrects Fini-Giovanardi; 23 January 2013 decree puts plant-origin compounds in Section B; 9 November 2015 decree and FM2 from December 2016archived
- GrowerIQ — Medical Cannabis Italy, Prescriptions & Access Guide (2026)2026 · 2007 first decree; 23 January 2013 decree enables prescriptions and pharmacy distribution; 2014 military production; FM1/FM2 strainsarchived
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.